| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |